Orsolya Cseprekal

Orsolya Cseprekal

Auto-generated profile, based on publicly available information

Orsolya Cseprekal

Department of Surgery, Transplantation and Gastroenterology, Semmelweis University , Budapest

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Journal Of Hypertension
Verified
Journal Article
Open access
JNJános Nemcsik
János Nemcsik
OCOrsolya Cseprekál
Orsolya Cseprekál
JEJózsef Egresits
József Egresits
JKJan Kielstein
Jan Kielstein
PKPhilipp Kümpers
Philipp Kümpers
ATAndrás Tislér
András Tislér
OBJECTIVE The role of biochemical and functional markers of microvascular dysfunction to predict cardiovascular outcomes in nondialyzed chronic kidney disease (CKD) remains unclear. In this prospective cohort study, we assessed whether biochemical [serum level of angiopoietin-2 (Ang-2), asymmetric and symmetric dimethylarginin] and functional (laser Doppler flowmetry) measures of microvascular function predicted cardiovascular events, cardiovascular and all-cause mortality in CKD patients. METHODS Postocclusive reactive hyperemia area (PORHHA), acetylcholine and sodium nitroprusside-mediated flow changes were estimated by laser Doppler flowmetry, and Ang-2, asymmetric and symmetric dimethylarginin were assessed in 105 CKD patients at baseline. Multiple failure time Cox-regression analyses with backward elimination were performed to determine the predictors of the combined endpoint of cardiovascular mortality and cardiovascular events or all-cause mortality and cardiovascular events during a median of 66.6 (interquartile range 39.8-80.4) months of follow-up. RESULTS In univariate models lnAng-2 and lnPORHHA both predicted the cardiovascular outcome besides age, diabetes, baseline cardiovascular disease, brachial pulse pressure and log C-reactive protein. In multivariate analysis lnPORHHA [hazard ratio: 0.66 (95% confidence interval: 0.49-0.89) per ln(mU s)], age [1.03 (1.01-1.06) per year], log C-reactive protein [1.31 (1.06-1.64) per ln(mg/l)] and diabetes [3.33 (1.70-6.53)] remained significant predictors of the cardiovascular outcome, whereas lnAng-2 did not enter the model. Neither of the microvascular variables were an independent predictor of all-cause mortality and cardiovascular events. CONCLUSION Among the functional and biochemical microvascular parameters PORHHA seems to improve cardiovascular risk assessment in CKD. Nevertheless the robustness of traditional risk factors seems to outweigh the role of microvascular biomarkers on all-cause mortality and cardiovascular events at this time.

1 December 2024 in Clinical Kidney Journal
Verified
Journal Article
Open access
OCOrsolya Cseprekal
Orsolya Cseprekal
CJChristian Jacquelinet
Christian Jacquelinet
ZMZiad Massy
Ziad Massy
Pre-emptive kidney transplantation (PKT) has long been considered the optimal treatment for patients with end-stage chronic kidney disease (CKD) seeking the most favourable long-term outcomes. However, the significant growth in transplant procedures over recent decades has led to a notable increase in wait-listed patients and a disproportionate demand for donor organs. This situation necessitates a re-evaluation of transplantation timing and the establishment of rational indications from both societal and clinical perspectives. An increasing number of retrospective analyses have challenged the universal benefit of PKT, suggesting that premature indications for living or deceased donor PKT may not always yield superior hard outcomes compared with non-PKT approaches. Conventional predictive models have shown limitations in accurately assessing risks for certain subpopulations, potentially leading to significant disparities among wait-listed patients. To address these challenges, we propose the following considerations. Prediction models should not only optimize the distribution of our limited donor resources, but should also illuminate foreseeable risks associated with a potentially ‘unsuccessful’ PKT. Therefore, this article seeks to underscore the necessity for further discourse on the smouldering concept of when and for whom living or deceased donor PKT should be considered. Is it universally beneficial, or should the clinical paradigm be re-evaluated? In the endeavour to attain superior post-PKT survival outcomes compared with non-PKT or conservative treatment, it seems critical to acknowledge that other treatments may provide more favourable results for certain individuals. This introduces the intricate task of effectively navigating the complexities associated with ‘too early’ or ‘unsuccessful’ PKT.

1 September 2017 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
JNJános Nemcsik
János Nemcsik
BKB. Korosi
B. Korosi
DBD. Batta
D. Batta
ALA. Laszlo
A. Laszlo
ATAdam Tabak
Adam Tabak
ZRZ. Rihmer
Z. Rihmer
Hypertension and mood disorders both increase the frequency of cardiovascular events. Affective temperaments are related to mood disorders, however, less data are available about the relationship between affective temperaments and cardiovascular diseases. The aim of this study was to evaluate affective temperament scores, depression, anxiety, hemodynamic and arterial stiffness parameters in healthy subjects (Cont), as well as in chronic, well-treated (Chr), chronic, resistant (Res) and white-coat (Wh) hypertensive patient populations. In our study, 261 patients were included: 148 Chr, 29 Res, 17 Wh and 67 Cont subjects. The patients completed the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire (TEMPS-A), the Beck Depression Inventory (BDI) and the Hamilton Anxiety Scale (HAMA). Blood pressure was measured with a validated oscillometric device (Omron M3) and arterial stiffness was examined with tonometry (PulsePen). Significant differences were found between the Cont, Chr, Res and Wh in brachial systolic blood pressure (121.44 ± 11.1, 131.66 ± 12.16, 151.1 ± 27.92, 136.31 ± 12.31 mmHg, respectively) and in pulse wave velocity (7.78 ± 1.39, 9.24 ± 2.19, 10.49 ± 2.76, 8.06 ± 1.61 m/s, resp.). In cyclothymic affective temperament scores we found significant differences between the Cont, Chr and Res groups (2(0–4), 3(1–5), 4(3–8), resp.) with the highest score in Res. In BDI scores also significant differences were found between Cont, Chr and Res (3(0–5), 5(2–9), 7(4–12.5), resp.), while in HAMA scores differences between Cont, Chr, Res and Wh (3(1–6), 5(2–9), 12 (6–19.5), 8(5–10.5), resp.) groups were found. Res group showed the worst BDI and HAMA profiles as well. Evaluation of affective temperaments might be helpful in identification of high-risk subgroups of hypertensive patients. However, prospective studies are required to confirm these observations.

29 April 2024 in Renal Failure
Verified
Journal Article
Open access
OCOrsolya Cseprekál
Orsolya Cseprekál
LRLaszlo Rosivall
Laszlo Rosivall
Budapest Nephrology School (BNS) could have celebrated its 30th event if it had not been interrupted by COVID pandemic for a few years. Yet, the organization of 27th BNS in August 2023 resumed its successful and traditional activities at Semmelweis University, in the beautiful central European city of Budapest. In over two decades, BNS has faithfully adapted to the changes and developments of medical science and clinical nephrology, the fact which has kept it unique and attractive for nephrologists from across the globe. With such a long history and representing the top international professors of nephrology, BNS has proved to be a successful one-week, in-person refreshing course which has attracted over 1600 medical doctors from more than 60 countries. It has well served as an academic meeting point suitable for networking and exchange of up-to-date knowledge presented by the best international experts in nephrology. The dedication and focus of these experts on education, research and patient care represent the very concept of translational medicine. The invaluable experience of the past 27 years has set the standards for BNS to contribute to the evolution of translational nephrology in Europe in the next decade.

8 February 2024 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
OCOrsolya Cseprekal
Orsolya Cseprekal
ACAmaryllis H Van Craenenbroeck
Amaryllis H Van Craenenbroeck
MBMartin H de Borst
Martin H de Borst
KSKate I Stevens
Kate I Stevens
AFAna Carina Ferreira
Ana Carina Ferreira
AWAndrzej Wiecek
Andrzej Wiecek
The future is for young people and so in an increasingly hectic world, investment in the younger generations is essential—not just through education but by simultaneously supporting their dreams and aspirations. Recognizing this, in 2013, Prof. Andrzej Wiecek championed the concept of the Young Nephrologists’ Platform (YNP). A decade has now passed since the YNP was created and it is an appropriate time, therefore, to reflect upon the activities and achievements of the platform (Table 1).

1 July 2019 in Journal Of Hypertension
Verified
Journal Article
Open access
JNJános Nemcsik
János Nemcsik
DBD. Batta
D. Batta
ATAdam Tabak
Adam Tabak
BKB. Korosi
B. Korosi
OCO. Cseprekal
O. Cseprekal
ATA. Tisler
A. Tisler
Our aim was to study the predictive power of ICPS risk categories on cardiovascular (CV) mortality in end-stage renal disease (ESRD) patients on hemodialysis therapy. In our retrospective cohort study 91 patients were involved from two dialysis centers. Pulse wave velocity (PWV), central systolic blood pressure (cSBP) and central pulse pressure (cPP) were measured with tonometric method, patients were followed for a median of 29.5 months and CV mortality was registered. Patients were classified into tertiles based on their PWV, cSBP and cPP values. After the analysis of the predictive values of the tertiles of the identical parameters, patients were scored. One score was given, when a patient had a third tertile value of cSBP or a second or third tertile value of PWV or cPP. Then the CV outcome was analyzed with Cox regression analysis of the groups of patients with different ICPS scores and three ICPS risk categories were defined: average (0–1 point), high (2 points) and very high (3 points). During follow-up 31 events occurred. After adjustment for multiple factors, compared with the average ICPS risk category group (n = 35; 38%), those, who were in the high risk group (n = 33; 30%) showed a tendency for significantly higher hazard ratio (HR) of CV mortality (HR = 2.62, 95% confidence interval (CI):0.82–8.43), while patients in the very high ICPS risk category (n = 23; 21%) had a markedly increased risk (HR = 10.03, CI:1.67–60.42). The ICPS risk categories can help in the identification of ESRD patients with high CV risk.